According to Zhitong Finance App, Baiben Healthcare (02293) issued an announcement. It is estimated that the net profit attributable to shareholders of the Group for the year ended June 30, 2026 will be approximately HK$6 million to HK$7 million, while the audited consolidated net profit attributable to shareholders for the year ended June 30, 2025 is approximately HK$17.5 million.

The Board believes that the reduction in net profit attributable to shareholders is mainly due to the following factors: The decline in the Group's earnings was mainly in the Institutional Healthcare Workforce Solutions segment, which fell from HK$35.1 million last year to around HK$22 million to HK$23 million. This reduction is due to the policies implemented by the Hong Kong Government to deal with the shortage of manpower. In particular, the Government introduced the Imported Labor Scheme to import nurses and nursing workers from overseas (mainly mainland China). These policies have increased the supply of labor for institutional healthcare customers and intensified market competition. Other losses increased by about HK$2 million to HK$3 million compared to last year, mainly due to exchange differences due to foreign currency transactions. The direct costs of the Clinic Services Division increased by about HK$2 million to HK$3 million, mainly due to the increase in medication and testing costs compared to last year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.